Medication info
Rabesto Tablet 20 mg (Rabeprazole Sodium)

Rabesto Tablet 20 mg (Rabeprazole Sodium)

Prescription medicationTabletOral
Ingredient · strength
Rabeprazole Sodium›20mg / 1 tablet
Manufacturer / importer
Huons Co., Ltd.
Appearance
Light yellow round enteric-coated tablet
Packaging
28 tablets (14 tablets per pack x 2)
Approval status
Active

MFDS item code 200702549 · Notified 2007.02.28 · Insurance code 670600490

Summary

Main use
Treatment of gastroesophageal reflux disease, peptic ulcers (including combination eradication therapy), and Zollinger-Ellison syndrome
Who takes it
Adults · Children
Adult dose
Gastric and duodenal ulcers The usual adult dose is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is usually given for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI, proton pump inhibitor), 10 mg or 20 mg may be administered orally twice daily for an additional 8 weeks. However, administration of 20 mg twice daily is limited to patients with confirmed severe mucosal damage. Relief of symptoms of gastroesophageal reflux disease Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is necessary. After symptoms resolve, subsequent symptoms may be controlled, as needed, with on-demand therapy using 10 mg once daily. Long-term maintenance therapy for gastroesophageal reflux disease Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication It is recommended that this drug 20 mg be administered concomitantly with clarithromycin 500 mg and amoxicillin 1 g twice daily for 7 days. Zollinger-Ellison syndrome The recommended initial dose for adults is 60 mg once daily. The dose may be adjusted up to 120 mg daily according to each patient's needs. Doses up to 100 mg may be administered once daily; the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have been treated with this drug for up to 1 year.
Child dose
Safety in pediatric patients has not been established.

Ingredients

Manufacturer
Huons Co., Ltd.

Efficacy & effects

Treatment of gastroesophageal reflux disease, peptic ulcers (including combination eradication therapy), and Zollinger-Ellison syndrome

  • Gastric ulcer
  • duodenal ulcer
  • erosive gastroesophageal reflux disease
  • ulcerative gastroesophageal reflux disease
  • gastrointestinal ulcer
  • Zollinger-Ellison syndrome
View approved original text

This medicine treats stomach ulcers and duodenal ulcers, and helps alleviate symptoms of erosive or ulcerative gastroesophageal reflux disease. Additionally, it is used for long-term maintenance therapy of gastroesophageal reflux disease and shows effectiveness when combined with antibiotics in patients with gastrointestinal ulcers infected by Helicobacter pylori. It is also used in the treatment of Zollinger-Ellison syndrome to improve various gastrointestinal issues. Therefore, this medicine is widely used for treating gastrointestinal ulcers and reflux diseases.

How to take

Adult dose

Gastric and duodenal ulcers The usual adult dose is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is usually given for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI, proton pump inhibitor), 10 mg or 20 mg may be administered orally twice daily for an additional 8 weeks. However, administration of 20 mg twice daily is limited to patients with confirmed severe mucosal damage. Relief of symptoms of gastroesophageal reflux disease Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is necessary. After symptoms resolve, subsequent symptoms may be controlled, as needed, with on-demand therapy using 10 mg once daily. Long-term maintenance therapy for gastroesophageal reflux disease Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication It is recommended that this drug 20 mg be administered concomitantly with clarithromycin 500 mg and amoxicillin 1 g twice daily for 7 days. Zollinger-Ellison syndrome The recommended initial dose for adults is 60 mg once daily. The dose may be adjusted up to 120 mg daily according to each patient's needs. Doses up to 100 mg may be administered once daily; the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have been treated with this drug for up to 1 year.

Child dose

Safety in pediatric patients has not been established.

Precautions

This medicine should not be used in patients with known allergies or hypersensitivity to certain ingredients. In particular, patients allergic to penicillin or macrolide antibiotics, those taking certain heart-related medications, and pregnant or breastfeeding women should avoid taking this product for safety reasons. Patients with impaired liver function or elderly individuals, as well as those with a history of drug allergies, should use this medicine with caution. This medicine may cause allergic reactions such as itching or rash, and if such symptoms occur, it should be discontinued immediately. Regular blood tests and liver function tests should be undertaken, and any unusual signs should be reported promptly, as side effects may occur in various organs including cardiac, gastrointestinal, nervous, respiratory, and skin systems. Long-term use of this medicine may increase the risk of bone fractures and decrease magnesium levels in the blood; thus, regular monitoring is advisable. Additionally, as it suppresses gastric acid secretion, there may be a slightly increased risk of bacterial infections in the stomach, so if diarrhea persists, consult a healthcare professional. Caution should be exercised while driving or operating machinery due to potential drowsiness or dizziness. There may be interactions with other medications, so inform healthcare providers about any other medications being taken, especially when taking antibiotics, antiviral agents, or anticoagulants. Pregnant or breastfeeding women should avoid this medicine, and its use in children is not recommended due to lack of established safety. Tablets should not be chewed or crushed, and should be swallowed whole. Keep in a sealed container to avoid exposure to air and store at a temperature between 1°C and 30°C. In case of overdose, there is no specific antidote, so appropriate treatment should be administered based on symptoms.

Side effects

Rash, urticaria, itching, erythrocytopenia, leukopenia, leukocytosis, eosinophilia, neutrophilia, lymphocytopenia, anemia, petechial hemorrhage, lymphadenopathy, hypochromic anemia, pancytopenia, agranulocytosis, thrombocytopenia, hemolytic anemia, ALT elevation, AST elevation, ALP elevation, γ-GTP elevation, LDH elevation, total bilirubin elevation, fulminant hepatitis, liver dysfunction, jaundice, hypertension, myocardial infarction, ECG abnormalities, migraine, syncope, angina pectoris, heart block, palpitations, bradycardia, tachycardia, pulmonary embolism, supraventricular tachycardia, thrombophlebitis, vasodilation, QTc prolongation, ventricular tachycardia, diarrhea, constipation, abdominal pain, abdominal distension, dyspepsia, belching, nausea, rectal bleeding, bloody stool, anorexia, cholelithiasis, oral ulcer, dysphagia, gingivitis, cholecystitis, increased appetite, abnormal stool, colitis, esophagitis, glossitis, pancreatitis, proctitis, thirst, vomiting, lower abdominal pain, gastric body, gastritis, stomatitis, dysgeusia, hemorrhagic diarrhea, cholangitis, duodenitis, gastrointestinal bleeding, hepatic encephalopathy, hepatitis, liver cancer, hepatic steatosis, sialadenitis, thirst, headache, insomnia, anxiety, dizziness, convulsions, abnormal dreams, decreased libido, neuropathy, sensory disturbances, tremors, weakness, irritability, drowsiness, vertigo, depression, restlessness, amnesia, confusion, extrapyramidal syndrome, hypervolemia, limb weakness, sensory dullness, decreased grip strength, language confusion, staggering, delirium, disorientation, hypersomnolence, cough, pharyngitis, rhinitis, dyspnea, asthma, epistaxis, laryngitis, hiccups, hyperventilation, bronchitis, sinusitis, apnea, respiratory depression, interstitial pneumonia, myalgia, low back pain, arthritis, leg cramps, bone pain, arthrosis, bursitis, hypertonicity, neuralgia, single contraction, sweating, alopecia, dry skin, shingles, psoriasis, skin pigmentation changes, toxic epidermal necrolysis, mucous membrane syndrome, erythema multiforme, cataracts, amblyopia, glaucoma, dry eyes, abnormal vision, tinnitus, otitis media, corneal opacity, blurriness, double vision, hearing loss, eye pain, retinal degeneration, strabismus, proteinuria, cystitis, frequent urination, dysmenorrhea, dysuria, nephrolithiasis, uterine bleeding, polyuria, gynecomastia, elevated total cholesterol, elevated triglycerides, elevated BUN, elevated serum thyroid-stimulating hormone, chest pain, chills, fever, urinary tract infection, erythema, fatigue, weight gain, visual disturbances, loss of appetite, neck stiffness, photosensitivity reaction, hangover effect, weight loss, gout, anaphylactic reaction, shock, hepatitis, jaundice, hepatic encephalopathy, sudden death, coma, hyperammonemia, rhabdomyolysis, delirium, angioedema, hypomagnesemia, thrombocytopenia, neutropenia, vesicular skin rash, systemic allergic reaction, joint pain, interstitial nephritis, gynecomastia, elevated thyroid-stimulating hormone, systemic lupus erythematosus reported in post-market studies, lupus erythematosus, halitosis, dry mouth, facial edema, flushing, palpitations.

Not everyone experiences these, and they can vary from person to person.

Storage

This medicine should be stored in a sealed container to prevent exposure to air, preferably at a temperature between 1°C and 30°C. Proper storage helps maintain the effectiveness of the medication for a longer period.

Appearance and packaging

Appearance

Light yellow round enteric-coated tablet

Package unit

28 tablets (14 tablets per pack x 2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.